跳至主要内容
临床试验/NCT02183727
NCT02183727终止2 期

L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction: A Prospective, Randomized Controlled Trial

Soft Tissue Regeneration, Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
发起方
入组人数
60
试验地点
1
主要终点
Physical Knee Function measured by the IKDC

研究概览

简要总结

The purpose of this study is to compare safety and efficacy outcomes of the L-C Ligament versus Hamstring Autograft for treatment of acute rupture of the ACL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with acute ruptures of the ACL who are willing to undergo treatment within 18 weeks of injury

排除标准

  • •Prior ACL reconstruction or other surgical procedure on the affected (target) knee
  • •Chronic ACL injury; interventional surgery scheduled 127 days or more after ACL injury
  • •Professional athletes currently engaged in active sport
  • •Prior distal femoral and/or proximal tibial fracture(s) of the target leg
  • •Previous or current ACL injury on contra-lateral leg
  • •Multi-ligament reconstruction
  • •Malalignment or varus thrust
  • •Patient > 193 cm tall (6' 4")
  • •The patient does not follow pre-operative rehabilitation that may have been prescribed post-injury (prior to Index Procedure)
  • •Confirmed connective tissue disorder
  • •Signs of moderate to severe degenerative joint disease
  • •Severe pain, swelling, or redness within 24 hours prior to surgery
  • •Complete or partial Posterior Cruciate Ligament (PCL) tear
  • •If concomitant meniscal injury is present, any of the following: 1/3rd meniscal resection; complex double-bucket tear; partially repaired meniscal tears
  • •Any type of lateral and/or medial meniscal tear which is not repairable (<2mm from rim)
  • •Additional concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion, that are not allowable under the Inclusion criteria
  • •The patient is unwilling to not participate in sporting activities for at least 9 months post-procedure
  • •The patient is mentally compromised
  • •The patient has a neuromuscular disorder that would engender unacceptable risk of knee instability, prosthesis fixation failure, or complications in postoperative care
  • •The patient has an active or latent infection in or about the affected knee joint or an infection site distant from the knee that may spread to the knee hematogenously
  • •Pregnant based on a positive beta hCG serum or an in vitro diagnostic test result or breast-feeding
  • •The patient is obese with a BMI > 35
  • •The patient has a known allergy to PLLA
  • •The patient has a medical condition or comorbidity that would interfere with study participation

研究组 & 干预措施

L-C Ligament

Experimental

Soft Tissue Regeneration's L-C Ligament is an investigation, interventional device intended for ACL reconstruction surgery within 18 weeks of acute rupture of the ACL and no previous surgical treatment. The L-C Ligament temporarily replaces the human anterior cruciate ligament (ACL) and provides a bioresorbable scaffold within and around which the native ACL will regenerate over time.

干预措施: L-C Ligament (Device)

Hamstring Autograft

Active Comparator

Hamstring autograft is the active comparator for this study. Autograft tissue is the gold-standard treatment for primary ACL reconstruction.

干预措施: Hamstring Autograft (Procedure)

结局指标

主要结局

Physical Knee Function measured by the IKDC

时间窗: 12 Months

Physical Knee Function at 12 Months post procedure

Graft Failure

时间窗: 12 Months

Revision surgery rate at one year

次要结局

  • Pain Score(Day 1)
  • Adverse event rates(12 months)

研究者

发起方
Soft Tissue Regeneration, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验